title: Management of common symptoms of advanced lung cancer.
abstract: Disease-directed treatment of lung cancer reduces the morbidity and extends life for patients. However, as providers we must recognize that treating the symptoms of the disease may be as important as the treatment of the disease itself. This is particularly true in advanced disease and after disease-directed therapies have been exhausted. Aggressive assessment of symptoms and use of palliative therapies can significantly reduce the symptomatology of advanced lung cancer. Though the impact of these symptoms (ie, pain, dyspnea, and cachexia) are well known, they tend to be under-treated. In addition, simple maneuvers such as opiate rotation for pain relief are underutilized. The diagnosis of lung cancer and its associated symptoms may result in severe psychosocial stress for the patient and further exacerbate the symptoms in a vicious cycle. Understanding of coping strategies may aid the medical provider in assisting the patient during his or her illness.
authors.affiliation: University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD 21201, USA. mbedor@umm.edu
authors.forename: Michelle
authors.initials: M
authors.lastname: Bedor
authors.forename: Carla
authors.initials: C
authors.lastname: Alexander
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Edelman
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use; D000855:Anorexia / Q000209:etiology; D002100:Cachexia / Q000209:etiology* / Q000628:therapy*; D004417:Dyspnea / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications*; D009017:Morbidity; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*; D011788:Quality of Life; D013315:Stress, Psychological; D015431:Weight Loss
chemical_list: D000701:Analgesics, Opioid